Want to join the conversation?
$AGN, which competes with $MYL and $AMGN, said that for 2016, it expects to launch a multi-dose preservative free formulation of RESTASIS, a new botox indication; ACZONE 7.5%; XEN Stent for glaucoma; Oculeve for dry eye. The company has more than 70 projects in mid-to-late stage development and has multiple programs in each therapeutic areas.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!